Access Pharmaceutical Treatment 
NORML
NOVEMBER 8, 2019
This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Once enacted, veterans will be able to access medical marijuana treatment without the added challenge of accessing a private, non-VA physician.
Americans for Safe Access
AUGUST 12, 2024
territories, often serving as a crucial alternative when conventional treatments have failed or as a safer option compared to pharmaceuticals. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
NORML
MAY 26, 2020
Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.” Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.
Cannabis Law Report
AUGUST 10, 2021
We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.
The Cannigma
AUGUST 5, 2022
When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?
NORML
JULY 1, 2019
Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “This year, my focus was on program improvements to further expand both access and therapeutic value to benefit the health and well-being of all Virginians.”
MGC Pharma
FEBRUARY 15, 2018
What will unrestricted access to Medicinal Cannabis look like in Australia? A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. kg of CBD and 163.7
Expert insights. Personalized for you.
248 
Let's personalize your content